Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Double interruption of antiplatelet therapy and tirofiban "bridging" for lung cancer resection.

Controtto F, Scacciatella P, Cristofori R, Grasso C, D'Amico M, Pennone M, Marra S.

Minerva Med. 2012 Aug;103(4):331-2. No abstract available.

PMID:
22805625
2.

Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel.

Savonitto S, D'Urbano M, Caracciolo M, Barlocco F, Mariani G, Nichelatti M, Klugmann S, De Servi S.

Br J Anaesth. 2010 Mar;104(3):285-91. doi: 10.1093/bja/aep373. Epub 2010 Jan 3.

PMID:
20047898
3.

Coronary stents and noncardiac surgery.

Riddell JW, Chiche L, Plaud B, Hamon M.

Circulation. 2007 Oct 16;116(16):e378-82. Review. No abstract available.

4.

Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes.

Solinas E, Gobbi G, Dangas G, Mehran R, Fahy M, Ippolito L, Bolognesi MG, Ruenes R, Merlini PA, Ardissino D, Vitale M.

J Thromb Thrombolysis. 2009 Jan;27(1):36-43. Epub 2007 Nov 30.

PMID:
18049795
5.

Tirofiban 'bridging' therapy for patients with drug-eluting stents undergoing non-cardiac surgery.

Bolsin S, Conroy M, Osborne C.

Br J Anaesth. 2010 Jun;104(6):779; author reply 779-80. doi: 10.1093/bja/aeq101. No abstract available.

PMID:
20460570
6.

[Thrombosis of pharmacoactive coronary endoprothesis after stopping antiplatelet treatment].

Saidi Y, Guesmi F, Landolsi M, Trabelsi S, Khemiri K, Ounalli K, Dziri C, Houissa M.

Tunis Med. 2010 Jan;88(1):63-4. French. No abstract available.

7.
8.

Randomised controlled trial evaluating the role of tirofiban in high-risk non-ST elevation acute coronary syndromes: an East Indian perspective.

Bhattacharya R, Pani A, Dutta D, Basak S, Gangopadhyay S, Das Baksi S, Sarkar RN.

Singapore Med J. 2010 Jul;51(7):558-64.

9.

No one-size-fits-all: A tailored approach to antithrombotic therapy after stent implantation.

Pfisterer M, Kaiser C, Jeger R.

Circulation. 2012 Jan 24;125(3):471-3. doi: 10.1161/CIRCULATIONAHA.111.078923. Epub 2011 Dec 16. No abstract available.

10.

[Late thrombosis in paclitaxel-eluting stent after discontinuation of clopidogrel medication - a case report with 2-year follow-up].

Wozakowska-Kapłon B, Młodnicki M, Gutkowski W.

Kardiol Pol. 2009 Mar;67(3):299-303; discussion 304. Polish.

11.

The year in interventional cardiology.

Dixon SR, Grines CL, O'Neill WW.

J Am Coll Cardiol. 2008 Jun 17;51(24):2355-69. doi: 10.1016/j.jacc.2008.03.021. Review. No abstract available.

12.

Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy.

D'Urbano M, Barlocco F, Poli A, Fetiveau R, Vandoni P, Savonitto S, De Servi S.

J Cardiovasc Med (Hagerstown). 2008 Jul;9(7):737-41. doi: 10.2459/JCM.0b013e3282f37e58.

PMID:
18545078
13.

Evaluation of triple anti-platelet therapy by modified thrombelastography in patients with acute coronary syndrome.

Ren YH, Yang TS, Wang Y, Gai LY, Liu HB, Chen L, Wang HY, Wang CY, Xu XL, Jin J, Xin YH, Li RB, Li HY, Lin L, Liu CX.

Chin Med J (Engl). 2008 May 5;121(9):850-2. No abstract available.

PMID:
18701053
14.

Drug eluting stents.

Gershlick AH, Richardson G.

BMJ. 2006 Dec 16;333(7581):1233-4. No abstract available.

15.

Duration of dual antiplatelet therapy after implantation of drug-eluting stents.

Park SJ, Park DW, Kim YH, Kang SJ, Lee SW, Lee CW, Han KH, Park SW, Yun SC, Lee SG, Rha SW, Seong IW, Jeong MH, Hur SH, Lee NH, Yoon J, Yang JY, Lee BK, Choi YJ, Chung WS, Lim DS, Cheong SS, Kim KS, Chae JK, Nah DY, Jeon DS, Seung KB, Jang JS, Park HS, Lee K.

N Engl J Med. 2010 Apr 15;362(15):1374-82. doi: 10.1056/NEJMoa1001266. Epub 2010 Mar 15.

16.

Dual oral antiplatelet therapy and unplanned surgery: possible role for intravenous platelet glycoprotein receptor inhibitors.

Bollati M, Giraudi E, Moretti C, Millesimo G, Sciuto F, Omedè P, Biondi Zoccai G, Sheiban I.

J Cardiovasc Med (Hagerstown). 2011 Sep;12(9):673-4. doi: 10.2459/JCM.0b013e328339d89a. No abstract available.

PMID:
21796059
17.

Clopidogrel in acute coronary syndromes.

Chua D, Ignaszewski A.

BMJ. 2009 Apr 14;338:b1180. doi: 10.1136/bmj.b1180. Review. No abstract available.

PMID:
19366756
18.

Which patients receiving warfarin can be treated safely with a drug-eluting stent?

Ryding AD, Banning AP.

Heart. 2008 Mar;94(3):275-7. doi: 10.1136/hrt.2007.121459. No abstract available.

PMID:
18276815
19.

Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel.

Furuta T.

Intern Med. 2009;48(21):1847-8. Epub 2009 Nov 2. No abstract available.

20.

Duration of clopidogrel therapy with drug-eluting stents.

Okura H.

N Engl J Med. 2010 Jul 29;363(5):488; author reply 490. doi: 10.1056/NEJMc1005624. No abstract available.

Supplemental Content

Support Center